Allogene Therapeutics Reports First Quarter 2022 Financial Results

Go back to Allogene Therapeutics Reports First Quarter 2022 Financial Results
(NASDAQ: ALLO) Delayed: 2.05 +0.07 (3.54%)
Previous Close $1.98    52 Week High
Open $1.96    52 Week Low
Day High $2.08    P/E N/A 
Day Low $1.92    EPS
Volume 4,597,466